Q3 Earnings Estimate for Atyr PHARMA Issued By HC Wainwright
Atyr PHARMA INC (NASDAQ:ATYR – Free Report) – Investment analysts at HC Wainwright reduced their Q3 2025 earnings estimates for shares of Atyr PHARMA in a note issued to investors on Thursday, May 8th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings per share of ($0.19) for the quarter, down […]
